Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)
| Autor: | Perez Elias M, Alejos B, Vivancos M, Ribera E, Galindo M, Vilanova-Trillo L, Fraile L, Moral S, De Lomas J, Lozano F, Garcia M, Pitarch M, Martinez M, Rojas J, Raya-Cruz M, Sepulveda M, Troya J, Del Campo S, Martinez E, Callau P, Moreno A, Casado J, Sanchez J, Ayerbe C, Negredo E, Campos I, Puig J, Torrella A, Planas B, Knobel H, Ferrando R, Crespo M, Sanz J, de Los Santos I, Diaz A, Carbonero L, de la Torre J, Reina M, Santos J, Maria C, Domenech G, Gutierrez M, Montero M, Cuellar S, Boix V, Payeras A, Ryan P, Torralba M, Cuadra F |
|---|---|
| Rok vydání: | 2019 |
| Zdroj: | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante Consejo Superior de Investigaciones Científicas (CSIC) |
| ISSN: | 0305-7453 |
| Popis: | Background Few women have been included in darunavir/cobicistat clinical development studies, and hardly any of them were antiretroviral experienced or treated with anything other than triple-based therapies. Objectives Our aim was to increase our knowledge about women living with HIV undergoing darunavir/cobicistat-based regimens. Methods A multicentre (21 hospitals), retrospective study including a centrally selected random sample of HIV-1 patients starting a darunavir/cobicistat-based regimen from June 2014 to March 2017 was planned. Baseline characteristics, 24 and 48week viral load response ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|